93 related articles for article (PubMed ID: 7528028)
21. Engineering of an FGF-proteoglycan fusion protein with heparin-independent, mitogenic activity.
Yoneda A; Asada M; Oda Y; Suzuki M; Imamura T
Nat Biotechnol; 2000 Jun; 18(6):641-4. PubMed ID: 10835602
[TBL] [Abstract][Full Text] [Related]
22. Studies on FGF-2: nuclear localization and function of high molecular weight forms and receptor binding in the absence of heparin.
Rifkin DB; Moscatelli D; Roghani M; Nagano Y; Quarto N; Klein S; Bikfalvi A
Mol Reprod Dev; 1994 Sep; 39(1):102-4; discussion 104-5. PubMed ID: 7999354
[TBL] [Abstract][Full Text] [Related]
23. High-affinity binding and activation of a truncated FGF receptor by both aFGF and bFGF.
Crumley G; Bellot F; Kaplow JM; Schlessinger J; Jaye M; Dionne CA
Oncogene; 1991 Dec; 6(12):2255-62. PubMed ID: 1722570
[TBL] [Abstract][Full Text] [Related]
24. Symmetric primary and tertiary structure mutations within a symmetric superfold: a solution, not a constraint, to achieve a foldable polypeptide.
Brych SR; Dubey VK; Bienkiewicz E; Lee J; Logan TM; Blaber M
J Mol Biol; 2004 Nov; 344(3):769-80. PubMed ID: 15533444
[TBL] [Abstract][Full Text] [Related]
25. The glycine box: a determinant of specificity for fibroblast growth factor.
Luo Y; Lu W; Mohamedali KA; Jang JH; Jones RB; Gabriel JL; Kan M; McKeehan WL
Biochemistry; 1998 Nov; 37(47):16506-15. PubMed ID: 9843417
[TBL] [Abstract][Full Text] [Related]
26. Acidic and basic fibroblast growth factor bind with differing affinity to the same heparan sulfate proteoglycan on BALB/c 3T3 cells: implications for potentiation of growth factor action by heparin.
Brown KJ; Hendry IA; Parish CR
J Cell Biochem; 1995 May; 58(1):6-14. PubMed ID: 7543903
[TBL] [Abstract][Full Text] [Related]
27. Conversion of type I 4:6 to 3:5 beta-turn types in human acidic fibroblast growth factor: effects upon structure, stability, folding, and mitogenic function.
Lee J; Dubey VK; Somasundaram T; Blaber M
Proteins; 2006 Mar; 62(3):686-97. PubMed ID: 16355415
[TBL] [Abstract][Full Text] [Related]
28. Production and functional characterization of human recombinant FGF-6 protein.
Pizette S; Batoz M; Prats H; Birnbaum D; Coulier F
Cell Growth Differ; 1991 Nov; 2(11):561-6. PubMed ID: 1814436
[TBL] [Abstract][Full Text] [Related]
29. Cleavage of K-FGF produces a truncated molecule with increased biological activity and receptor binding affinity.
Bellosta P; Talarico D; Rogers D; Basilico C
J Cell Biol; 1993 May; 121(3):705-13. PubMed ID: 8387532
[TBL] [Abstract][Full Text] [Related]
30. Mutagenesis of the nuclear localization sequence in EGF-1 alters protein stability but not mitogenic activity.
Friedman S; Zhan X; Maciag T
Biochem Biophys Res Commun; 1994 Feb; 198(3):1203-8. PubMed ID: 7509598
[TBL] [Abstract][Full Text] [Related]
31. FGFs and their receptors, in vitro and in vivo studies: new FGF receptor in the brain, FGF-1 in muscle, and the use of functional analogues of low-affinity heparin-binding growth factor receptors in tissue repair.
Soulet L; Chevet E; Lemaitre G; Blanquaert F; Meddahi A; Barritault D
Mol Reprod Dev; 1994 Sep; 39(1):49-54; discussion 54-5. PubMed ID: 7528027
[TBL] [Abstract][Full Text] [Related]
32. Analysis of putative heparin-binding domains of fibroblast growth factor-1. Using site-directed mutagenesis and peptide analogues.
Wong P; Hampton B; Szylobryt E; Gallagher AM; Jaye M; Burgess WH
J Biol Chem; 1995 Oct; 270(43):25805-11. PubMed ID: 7592764
[TBL] [Abstract][Full Text] [Related]
33. Amphibian FGF-1 is structurally and functionally similar to but antigenically distinguishable from its mammalian counterpart.
Patrie K; Botelho MJ; Ray SK; Mehta VB; Chiu IM
Growth Factors; 1997; 14(1):39-57. PubMed ID: 9086327
[TBL] [Abstract][Full Text] [Related]
34. The release of fibroblast growth factor-1 from NIH 3T3 cells in response to temperature involves the function of cysteine residues.
Jackson A; Tarantini F; Gamble S; Friedman S; Maciag T
J Biol Chem; 1995 Jan; 270(1):33-6. PubMed ID: 7529229
[TBL] [Abstract][Full Text] [Related]
35. Engineering of fibroblast growth factor: alteration of receptor binding specificity.
Seddon AP; Aviezer D; Li LY; Böhlen P; Yayon A
Biochemistry; 1995 Jan; 34(3):731-6. PubMed ID: 7827030
[TBL] [Abstract][Full Text] [Related]
36. Differential transforming abilities of non-secreted and secreted forms of human fibroblast growth factor-1.
Forough R; Xi Z; MacPhee M; Friedman S; Engleka KA; Sayers T; Wiltrout RH; Maciag T
J Biol Chem; 1993 Feb; 268(4):2960-8. PubMed ID: 7679105
[TBL] [Abstract][Full Text] [Related]
37. SHuffle™ T7 strain is capable of producing high amount of recombinant human fibroblast growth factor-1 (rhFGF-1) with proper physicochemical and biological properties.
Nasiri M; Babaie J; Amiri S; Azimi E; Shamshiri S; Khalaj V; Golkar M; Fard-Esfahani P
J Biotechnol; 2017 Oct; 259():30-38. PubMed ID: 28827102
[TBL] [Abstract][Full Text] [Related]
38. Redesigning symmetry-related "mini-core" regions of FGF-1 to increase primary structure symmetry: thermodynamic and functional consequences of structural symmetry.
Dubey VK; Lee J; Blaber M
Protein Sci; 2005 Sep; 14(9):2315-23. PubMed ID: 16081654
[TBL] [Abstract][Full Text] [Related]
39. Probing the role of proline -135 on the structure, stability, and cell proliferation activity of human acidic fibroblast growth factor.
Davis JE; Alghanmi A; Gundampati RK; Jayanthi S; Fields E; Armstrong M; Weidling V; Shah V; Agrawal S; Koppolu BP; Zaharoff DA; Kumar TKS
Arch Biochem Biophys; 2018 Sep; 654():115-125. PubMed ID: 30031837
[TBL] [Abstract][Full Text] [Related]
40. An FGF1:FGF2 chimeric growth factor exhibits universal FGF receptor specificity, enhanced stability and augmented activity useful for epithelial proliferation and radioprotection.
Motomura K; Hagiwara A; Komi-Kuramochi A; Hanyu Y; Honda E; Suzuki M; Kimura M; Oki J; Asada M; Sakaguchi N; Nakayama F; Akashi M; Imamura T
Biochim Biophys Acta; 2008 Dec; 1780(12):1432-40. PubMed ID: 18760333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
